Original Research
Accepted on 30 Jan 2026
Identification of Predictive Biomarkers and Dose Optimization for Camrelizumab Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma: A Quantitative Systems Pharmacology Approach
in Systems Immunology